It is well recognised that chronic otitis media (COM) is a risk factor for sensorineural hearing loss. Studies on the effect of COM on vestibular function have been beset by design biases. The authors designed a case control study to...
3 September 2021
| David John Howard (Prof), Vik Veer
|
ENTA - Otology
The pandemic has driven innovation in ways that we have not seen for many decades. Intensive care medicine and ENT have been at the forefront of these advances, and our good friends David Howard (never one to put his feet...
Otitis media (OM), a common disease of childhood, is considered to be a complex trait with multiple genetic and environmental factors expected to contribute to a child’s risk of developing recurrent acute OM (rAOM; ≥3 episodes in 6 months or...
1 September 2014
| Johan Fagan (Prof)
|
ENTA - ENT
I have been asked to share some of the initiatives I have been involved with to address ENT-related challenges in Africa and the developing world. Developing countries constitute the majority of the world’s landmass (Figure 1), are home to >50%...
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...
21st January 2021 Back to basics Yesterday I went right back to where my medical career began. I grew up in Germany, bilingual. A prerequisite to studying medicine in Germany is that applicants have to spend two months working as...
Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...
Prof Furness in this article rounds up the steps and leaps being made by the scientific community to develop therapies to support, rejuvenate and / or replace the cochlear structures. David’s electron microscope images of the cochlear structures are world...
Ameloblastoma is an odontogenic tumour that is benign but locally aggressive and is associated with local recurrence. They are rare, accounting for 1% of oral tumours, and occur almost exclusively in the jaws. It is more common in the mandible...
Epistaxis is the most common presentation to acute ENT services in the UK. However, there are currently no nationally accepted guidelines for its management. The British Rhinological Society, ENT UK and INTEGRATE (The National ENT Trainee Research Network) are working...
We are honoured to welcome renowned head and neck surgeon, Professor Jatin Shah as Guest Editor of this edition of ENT and Audiology News. Here he speaks to Section Editor, Charlie Giddings, about his career, memorable achievements and advice for...